Publications by authors named "I Raz"

Claim this Profile
G
Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58.
Paul M Haller, Stephen D Wiviott, David D Berg, Petr Jarolim, Erica L Goodrich, Itamar Raz

ESC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants.
Sean J Jurgens, Giorgio E M Melloni, Shinwan Kany, Larissa Fabritz, Joel T Rämö, Itamar Raz

J Am Coll Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gestational Diabetes-Screening, Prevalence and Postpartum Diabetes: Population-Based Cohort Study.
Miri Lutski, Mor Saban, Debbie Novick, Amir Tirosh, Itamar Raz

Diabetes Metab Res Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes.
Mohamad Suki, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Itamar Raz

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic.
Mohamad Suki, Ashraf Imam, Johnny Amer, Yael Milgrom, Muhammad Massarwa, Itamar Raz

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis